Anti-inhibitor Coagulant Complex (Human) and Burosumab-twza Subcutaneous
Determining the interaction of Anti-inhibitor Coagulant Complex (Human) and Burosumab-twza Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: anti-inhibitor coagulant complex
Brand name: Feiba, Feiba VH Immuno, Autoplex T, Feiba NF
Synonyms: Anti-inhibitor coagulant complex
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Anti-inhibitor Coagulant Complex (Human)-Buspar
- Anti-inhibitor Coagulant Complex (Human)-Buspar Dividose
- Anti-inhibitor Coagulant Complex (Human)-Buspirone
- Anti-inhibitor Coagulant Complex (Human)-Buspirone Hydrochloride
- Anti-inhibitor Coagulant Complex (Human)-Busulfan
- Anti-inhibitor Coagulant Complex (Human)-Busulfan Concentrate Injection
- Burosumab-twza Subcutaneous-Anti-inhibitor coagulant complex Intravenous
- Burosumab-twza Subcutaneous-Anti-Itch (Diphenhydramine (Topical))
- Burosumab-twza Subcutaneous-Anti-Itch Maximum Strength
- Burosumab-twza Subcutaneous-Anti-thymocyte globulin rabbit
- Burosumab-twza Subcutaneous-Antibiotic Cream Topical
- Burosumab-twza Subcutaneous-Antibiotic Otic